Mitochondrial phosphoenolpyruvate carboxykinase promotes tumor growth in estrogen receptor‐positive breast cancer via regulation of the mTOR pathway

BACKGROUND: Tumor cells may aberrantly express metabolic enzymes to adapt to their environment for survival and growth. Targeting cancer‐specific metabolic enzymes is a potential therapeutic strategy. Phosphoenolpyruvate carboxykinase (PEPCK) catalyzes the conversion of oxaloacetate to phosphoenolpy...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Hui‐Ping, Chu, Pei‐Yi, Chang, Tsung‐Ming, Huang, Kuo‐Wei, Hung, Wen‐Chun, Jiang, Shih Sheng, Lin, Hui‐You, Tsai, Hui‐Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883444/
https://www.ncbi.nlm.nih.gov/pubmed/35757841
http://dx.doi.org/10.1002/cam4.4969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9883444/
https://www.ncbi.nlm.nih.gov/pubmed/35757841
http://dx.doi.org/10.1002/cam4.4969

Ejemplares similares